Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial

Leukemia. 2006 Apr;20(4):748-50. doi: 10.1038/sj.leu.2404122.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Administration, Oral
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Drug Administration Schedule
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Injections, Intravenous
  • Leukemia, Myeloid / diagnosis
  • Leukemia, Myeloid / drug therapy*
  • Male
  • Middle Aged
  • Recurrence
  • Remission Induction
  • Survival Rate
  • Treatment Outcome
  • Tretinoin / administration & dosage

Substances

  • Tretinoin
  • Etoposide
  • Idarubicin